Rapport Therapeutics (RAPP) Shares Sink 20% After Hours
· benzinga.com · popularity 17/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at benzinga.com →
Summary
Rapport Therapeutics Inc. (NASDAQ: RAPP) shares fell 20.04% to $22.02 in after-hours trading Tuesday. Rapport Therapeutics is a clinical-stage …
Found in: Stocks. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 13.